Streetbeat News

Revenues

RLAY

Relay Therapeutics (NASDAQ:RLAY) has been analyzed by 5 analysts, showing a range of sentiments from bullish to somewhat bullish. The average 12-month price target has decreased by 8.93% to $20.4. Analysts have adjusted their ratings and price targets, reflecting dynamic market conditions and company performance. Despite significant revenue growth, the company faces challenges with ROE and ROA below industry standards.

Portfolio Pulse from Benzinga Insights

July 17, 2024 | 12:01 pm

VLO

Valero Energy (NYSE:VLO) has received mixed analyst ratings over the past three months, with a recent trend towards more neutral or slightly bullish outlooks. The average 12-month price target has decreased to $173.23 from $178.31. Analysts have adjusted their ratings and price targets based on evolving market conditions and company performance. Despite a recent revenue decline, Valero maintains strong profitability and financial health.

Portfolio Pulse from Benzinga Insights

July 17, 2024 | 12:01 pm

BLBD

Analysts have shared mixed evaluations of Blue Bird (NASDAQ:BLBD) over the past three months, with a majority being bullish. The average 12-month price target has increased to $53.43, with recent upgrades from several analysts. Blue Bird has shown strong financial performance with notable revenue growth, net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

July 17, 2024 | 12:01 pm

LRHC

La Rosa Holdings reported a 21% increase in transaction aggregate sales value, reaching just under $110 million.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 12:00 pm

LRHC

La Rosa Holdings Corp. (NASDAQ:LRHC) reported a 15% increase in Q2 transaction volume and a 21% rise in total transaction value, nearly reaching $110 million. The growth is attributed to strategic initiatives and the addition of new agents. The company expects significant year-over-year revenue growth.

Portfolio Pulse from Shivani Kumaresan

July 17, 2024 | 12:00 pm

LRHC

La Rosa Holdings reported a 15% increase in real estate sales transaction volume in Q2 2024 compared to Q1 2024.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 12:00 pm

AEHR

Aehr Test Systems shares are trading higher following better-than-expected Q4 financial results and FY25 revenue guidance above estimates. The company also announced a stock purchase agreement and $12.7 million in orders for its FOX WaferPak full wafer Contractors.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 11:49 am

GFAI

Guardforce AI's subsidiary in Mainland China has significantly expanded its contracts with two long-term retail clients, enhancing its business prospects.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 11:34 am

ALLY

Ally Financial (NYSE: ALLY) reported Q2 2024 adjusted EPS of $0.97, beating the $0.64 estimate by 51.56%. Adjusted revenue was $2.042 billion, slightly above the $2.030 billion estimate but down 1.16% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 11:29 am

FBTC

IBIT

Bitcoin surged above $66,000 before settling at $64,980, driven by renewed bullish sentiment and institutional interest. Ethereum also saw gains. Notable inflows into Bitcoin ETFs, including BlackRock's IBIT and Fidelity's FBTC, highlight sustained institutional confidence. The market absorbed significant sell-offs, including from the German state of Saxony, and remains cautious about the ongoing Mt. Gox Bitcoin repayments.

Portfolio Pulse from Murtuza Merchant

July 17, 2024 | 11:23 am